You are here

Cobenfy

Will Cobenfy’s clinical stumble derail a once-predicted rise?

Pharma Voice

Tue, 04/29/25 - 08:12 am

Bristol Myers Squibb

clinical trials

Bristol Myers says schizophrenia drug launch ‘off to a solid start’

BioPharma Dive

Thu, 04/24/25 - 09:11 pm

Bristol Myers Squibb

Cobenfy Falls Short in Phase 3 ARISE Trial as Adjunctive Schizophrenia Therapy

HCP Live

Tue, 04/22/25 - 07:38 pm

Bristol Myers Squibb

clinical trials

Reviva’s antipsychotic shows promise against schizophrenia symptoms in year-long study

Fierce Biotech

Mon, 12/16/24 - 11:29 am

Bristol Myers Squibb

clinical trials

Bristol Myers partner Zai Lab plots KarXT filing in China after trial win

Fierce Pharma

Tue, 10/29/24 - 08:00 pm

Bristol Myers Squibb

For Bristol Myers Squibb's newly approved schizophrenia drug, what a long, strange trip it's been

Fierce Pharma

Mon, 10/7/24 - 11:16 am

Bristol Myers Squibb

Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years

Medical Marketing and Media

Mon, 09/30/24 - 09:28 am

Bristol Myers Squibb